Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Income towards Parent Company: 2021-2024

Historic Income towards Parent Company for Immunocore Holdings (IMCR) over the last 4 years, with Dec 2024 value amounting to -$51.1 million.

  • Immunocore Holdings' Income towards Parent Company fell 102.24% to -$196,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.3 million, marking a year-over-year increase of 37.83%. This contributed to the annual value of -$51.1 million for FY2024, which is 7.60% up from last year.
  • Latest data reveals that Immunocore Holdings reported Income towards Parent Company of -$51.1 million as of FY2024, which was up 7.60% from -$55.3 million recorded in FY2023.
  • In the past 5 years, Immunocore Holdings' Income towards Parent Company registered a high of -$51.1 million during FY2024, and its lowest value of -$179.6 million during FY2021.
  • In the last 3 years, Immunocore Holdings' Income towards Parent Company had a median value of -$52.5 million in 2022 and averaged -$53.0 million.
  • Per our database at Business Quant, Immunocore Holdings' Income towards Parent Company skyrocketed by 70.75% in 2022 and then fell by 5.22% in 2023.
  • Immunocore Holdings' Income towards Parent Company (Yearly) stood at -$179.6 million in 2021, then skyrocketed by 70.75% to -$52.5 million in 2022, then dropped by 5.22% to -$55.3 million in 2023, then rose by 7.60% to -$51.1 million in 2024.